middle.news
4DMedical Accelerates CT:VQ Adoption with $233m Raise and EU, UK Clearances
9:54am on Thursday 30th of April, 2026 AEST
•
Healthcare
Read Story
4DMedical Accelerates CT:VQ Adoption with $233m Raise and EU, UK Clearances
9:54am on Thursday 30th of April, 2026 AEST
Key Points
Expanded CT:VQ™ adoption at five leading US academic medical centres
CE Mark and UKCA regulatory clearances enable European and UK rollout
$233 million raised through two institutional placements in 2026
New contract with GlaxoSmithKline for pulmonary drug development analytics
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
4Dmedical (ASX:4DX)
OPEN ARTICLE